BB Biotech AG
🇬🇧XLON.0JYOUnited KingdomHealthcare
Price£51.45+0.47 (+0.92%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 1
- Medium: 1
- Low: 0
Net margin: collapsed against the prior period
Operating income: crossed zero, from positive to negative
Free with a Finzer account.
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- CH0038389992
- CUSIP
- Not reported
Company
- Employees
- 10
- Headquarters
- Küsnacht, Germany
Market
- Shares outstanding
- 55.4M
- Market cap
- £2.54B
Highlights
- Market cap
- £2.54B
- EPS LTM
- -CHF 8.01
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- -CHF 176.15M-152.93%down year on year
- Net income
- -CHF 438.69M-287.36%down year on year
- Gross margin
- 99.77%-20.75%down year on year
- Free cash flow
- CHF 435.73M+317.02%up year on year
Latest news
News is not sourced for this exchange.
Business summary
BB Biotech AG is a company in the healthcare sector, listed on London Stock Exchange (United Kingdom) under the ticker 0JYO. Its market capitalisation is £2.54B, from 55.4M shares outstanding, as of . Across the 248 trading sessions to the shares traded between £35.70 and £56.90, and the last close of £51.45 sits 74% of the way up that range. The company is headquartered in Küsnacht, Germany, and employs about 10 people. This is the London Stock Exchange listing of BB Biotech AG; its primary listing is BION on SIX Swiss Exchange.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.